Home BioCrea

BioCrea

acquired
-
A biopharmaceutical company

Basic Information

BioCrea is a developer of CNS drugs. The company develops drugs for various diseases in Germany, such as depression, Huntington's disease, epilepsy, autism, and amyotrophic lateral sclerosis (ALS).
BioCrea
Montreal,Quebec,Canada
unclear
January 01, 2004
oligos@biocorp.ca